Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180)
Product Sizes
100 ug
SPD-M180-100UG
1 mg
SPD-M180-1MG
About this Product
- SKU:
- SPD-M180
- Buffer:
- PBS
- translate.label.attr.clone:
- AM180
- Clonality:
- Recombinant Monoclonal
- Extra Details:
- Anti-SARS-CoV-2 RBD Potent Neutralizing Antibody, Human IgG1 (AM180) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293). This antibody recognizes the SARS-CoV-2 Spike Protein RBD domain and inhibits the interaction between SARS-CoV-2 RBD and ACE2 with an IC50 of 0.98 ug/mL using SARS-CoV-2 Inhibitor Screening Kit.Pseudovirus assay shows that this antibody has potent neutralizing activity against pseudovirus bearing SARS-CoV-2 Spike protein.
- Immunogen:
- Spike RBD
- Physical State:
- Powder
- Purification:
- 95%
- Reactivities:
- Human
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C
- Supplier:
- ACRO Biosystems
- Type:
- Antibody: Recombinant Antibodies
